UnitedHealth Group has reported Q3 results that show steady revenue growth and disciplined execution despite continued cost pressures and reimbursement challenges.
The company said its focus remains on strengthening performance, refining operations and positioning for durable growth into 2026 and beyond.
Consolidated revenues for the quarter reached $113.2 billion, up 12% year-over-year. Earnings from operations were $4.3 billion, with a net margin of 2.1%. Adjusted earnings per share stood at $2.92, while the GAAP figure was $2.59.
The company's medical care ratio (MCR) came in at 89.9%, consistent with Q2 expectations but up 470 basis points year-over-year, largely due to elevated medical cost trends and the continued effects of Medicare funding reductions and changes to the Part D program under the Inflation Reduction Act. Favorable reserve development totaled $80 million for the quarter.
UnitedHealthcare, the company’s core insurance business, posted revenues of $87.1 billion, up 16% year-over-year, driven by growth in its Medicare & Retirement and Community & State segments. UnitedHealthcare now serves 50.1 million members in the US, an increase of nearly 800,000 from a year earlier. However, operating earnings declined 57% to $1.8 billion, reflecting higher utilization rates and margin pressure from regulatory adjustments.
Optum, UnitedHealth’s health services arm, reported revenues of $69.2 billion, up 8% year-over-year, led by strong growth in its Optum Rx pharmacy segment. Optum Rx’s revenues climbed 16% to $39.7 billion, supported by new client wins and higher prescription volumes, though margins narrowed slightly due to a shift toward higher-cost drugs.
Operating cash flow reached $5.9 billion, representing 2.3 times net income, while the company’s debt-to-capital ratio remained steady at 44.1%, inclusive of its recent acquisition of Amedisys.
The healthcare and insurance giant raised its full-year 2025 earnings outlook to at least $14.90 per share in net earnings and $16.25 in adjusted net earnings, reflecting confidence in its underlying performance.
UnitedHealth’s results reflect the continued impact of US policy changes and cost inflation across the health care system, but the company maintained that its diversified structure and focus on operational efficiency position it for long-term growth and margin recovery into 2026.
UnitedHealth Group is one of the best health insurance companies by market share. Compare and identify strong partners for your broker business.
